Startseite Preventive Effects of an Extract of Erythrina Lysistemon (Fabaceae) on Some Menopausal Problems: Studies on the Rat
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Preventive Effects of an Extract of Erythrina Lysistemon (Fabaceae) on Some Menopausal Problems: Studies on the Rat

  • Dieudonné Njamen , Chantal Béatrice Magne Ndé , Zacharias Tanee Fomum und Jean Claude Mbanya
Veröffentlicht/Copyright: 18. September 2007

Objective - Our purpose was to determine the advantage of early treatment (before ovariectomy) on a preventive basis of an ethyl acetate extract of Erythrina lysistemon (EL) on menopausal signs, an extract which has previously shown estrogenic activity by acting through the oestrogen receptors.Methods - Female Wistar rats aged 1-1.5 month were randomised in groups and treated respectively from 28 days before ovariectomy to 84 days after. The fasting lipids levels, glucose tolerance, bone and uterine weight, uterine and vaginal epithelial height were determined at days 0, 28, 56 and 84; whereas body weight was determined every forth night.Results - Oral administration of 200mg/kg/d of EL significantly increased HDL-cholesterol and LDL-cholesterol levels on days 0 and 28 and decreased them at days 56 (70%) and 84 (48.27%) compared to untreated ovariectomized rats. It also significantly increased bone weight. Further, EL at day-56 controlled glucose intolerance; but it failed to do so at day-84 and significantly increased blood glucose level. At day 0, EL significantly decreased uterine weight of animals as well as E1. In contrast 28 days after ovariectomy, EL significantly increased uterine weight (36.43%), uterine (19.71%) and vaginal (31.76%) epithelial height with a more advance vaginal cornification compared to controls.Conclusion - These results suggest that oral administration of 200mg/kg/d of EL 28 days before ovariectomy prevented bone loss. EL had a transient effect on glucose intolerance. However EL significantly increased HDL-cholesterol and decreased TG levels.

Published Online: 2007-9-18

©2011 Walter de Gruyter GmbH & Co. KG, Berlin/Boston

Artikel in diesem Heft

  1. Review Article
  2. Pharmacology of Huperzine A, an Alkaloid Isolated from Huperzine Serrata, a Novel Cognition Enhancer with Dual Cholinergic and NMDA Action. Implications in Schizophrenia and Dementia
  3. Research Article
  4. Fuzzy Rule Based Systems in Classification of Terminalia Chebula Fruits of Complementary and Alternative Medicine
  5. A Natural, Multi-Mechanistic Supplement Approach for Improving Cardiovascular Risk Factors
  6. How Do Private CAM Therapies Affect Integrative Health Care Settings in a Publicly Funded Health Care System?
  7. Preventive Effects of an Extract of Erythrina Lysistemon (Fabaceae) on Some Menopausal Problems: Studies on the Rat
  8. Bridge Building and Integrative Treatment of People with Multiple Sclerosis. Research-based Evaluation of a Team-building Process
  9. The Effects of Honey Compared With Sucrose and a Sugar-free Diet on Neutrophil Phagocytosis and Lymphocyte Numbers after Long-term Feeding in Rats
  10. Effect of Andrographolide on Monkey Hepatocytes against Galactosamine Induced Cell Toxicity : An In-Vitro Study
  11. Ginger Modulates Lymphocyte Activity in Vitro and in Vivo and Modestly Prolongs Cardiac Allograft Survival
  12. Discussion Paper
  13. Orthodox Use, or Misuse, of Complementary & Alternative Medicine
  14. Using the Behavioral Model for Complementary and Alternative Medicine: The CAM Healthcare Model
  15. Conference Presentation
  16. Coming of Age -- Emerging Issues and New Directions in CAM Research: Abstracts from the Fourth Annual IN-CAM Symposium November 1 & 2, 2007, Vancouver, Canada
Heruntergeladen am 23.9.2025 von https://www.degruyterbrill.com/document/doi/10.2202/1553-3840.1092/html
Button zum nach oben scrollen